Home › Companies › TWIST BIOSCIENCE CORP. › 2023-2024

TWIST BIOSCIENCE CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TWIST BIOSCIENCE CORP.’s Form 8-K, filed February 7, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

4Ballot items
257Asset managers
1,263Fund votes
February 6, 2024Meeting date

Results at a glance

Meeting of February 6, 2024: 4 items on TWIST BIOSCIENCE CORP.’s Form 8-K, filed February 7, 2024: 2 approved · 2 without a stated outcome.

Material dissent

Elect Director: Emily M. Leproust, Ph.D. 74% of votes cast Outcome not stated Director under 80%
Elect Director: Robert Chess 60% of votes cast Outcome not stated Director under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TWIST BIOSCIENCE CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TWIST BIOSCIENCE CORP.

These tallies are TWIST BIOSCIENCE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed February 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TWIST BIOSCIENCE CORP. — official shareholder meeting results, meeting held February 6, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Emily M. Leproust, Ph.D.	33,957,330	--	--	12,194,829	6,148,005	74%	Not verified	—
Elect Director: Robert Chess	27,503,789	--	--	18,648,370	6,148,005	60%	Not verified	—
2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")	43,215,571	2,904,714	31,874	--	6,148,005	94%	Approved	—
3. Ratification of Appointment of Independent Registered Accounting Firm	52,195,318	61,548	43,298	--	--	99.8%	Approved	—

Source: TWIST BIOSCIENCE CORP., Form 8-K, filed with the SEC on February 7, 2024 — read the filing on EDGAR.

How asset managers voted at the TWIST BIOSCIENCE CORP. 2023-2024 meeting

Each item below shows how the 257 asset managers that disclosed a TWIST BIOSCIENCE CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Emily M. Leproust, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD

FOR: 33,957,330WITHHELD: 12,194,829

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Class III Directors: Emily M. Leproust, Ph.D.

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Emily M. Leproust, Ph.D.”): 33,957,330 for, 12,194,829 withheld, per its Form 8-K filed February 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 21,961,873 for, 3,079,222 withheld, 51,348 abstained.

FOR

FOR: 21,961,873ABSTAIN: 51,348WITHHOLD: 3,079,222

Largest asset managers voting on “Election of Class III Directors: Emily M. Leproust, Ph.D.” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
ARK ETF Trust	6,775,445	0	0	For
Vanguard	5,376,144	0	0	For
State Street	1,993,354	0	1,380	For
Artisan	1,611,932	0	0	For
BlackRock	1,223,059	0	0	For
Invesco	930,956	0	0	For
BNY Mellon	882,394	0	0	For
Dimensional	0	0	859,476	Withhold
JPMorgan	782,827	0	0	For
WILLIAM BLAIR FUNDS	0	0	756,519	Withhold
Charles Schwab	448,232	0	0	For
AIG/SunAmerica	0	0	261,088	Withhold
Bridge Builder Trust	244,362	12,039	0	For
Fidelity	63,035	0	181,306	Mixed
Direxion Shares ETF Trust	0	0	229,799	Withhold
OLD WESTBURY FUNDS INC	0	0	216,180	Withhold
Brighthouse	179,224	0	19,786	Mixed
Equitable	112,469	0	59,444	Mixed
TIAA	168,671	0	0	For
Jackson National	141,214	12,931	0	Mixed
AMERICAN BEACON FUNDS	138,146	0	0	For
Columbia Threadneedle	132,700	0	0	For
FRANKLIN STRATEGIC SERIES	119,862	0	0	For
Global X	104,320	0	0	For
First Trust	0	0	96,906	Withhold

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

2. Elect Director: Robert Chess

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%WITHHELD

FOR: 27,503,789WITHHELD: 18,648,370

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: Election of Class III Directors: Robert Chess

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Robert Chess”): 27,503,789 for, 18,648,370 withheld, per its Form 8-K filed February 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 60% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 17,450,548 for, 7,449,333 withheld, 192,562 abstained.

FORWITHHOLD

FOR: 17,450,548ABSTAIN: 192,562WITHHOLD: 7,449,333

Largest asset managers voting on “Election of Class III Directors: Robert Chess” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
ARK ETF Trust	6,775,445	0	0	For
Vanguard	5,376,144	0	0	For
State Street	1,243	0	1,993,491	Withhold
Artisan	1,611,932	0	0	For
BlackRock	1,223,059	0	0	For
Invesco	0	0	930,956	Withhold
BNY Mellon	0	0	882,394	Withhold
Dimensional	0	0	859,476	Withhold
JPMorgan	782,827	0	0	For
WILLIAM BLAIR FUNDS	0	0	756,519	Withhold
Charles Schwab	448,232	0	0	For
AIG/SunAmerica	0	0	261,088	Withhold
Bridge Builder Trust	244,362	12,039	0	For
Fidelity	63,035	0	181,306	Mixed
Direxion Shares ETF Trust	0	0	229,799	Withhold
OLD WESTBURY FUNDS INC	0	0	216,180	Withhold
Brighthouse	0	0	199,010	Withhold
Equitable	112,469	0	59,444	Mixed
TIAA	168,671	0	0	For
Jackson National	0	154,145	0	Abstain
AMERICAN BEACON FUNDS	138,146	0	0	For
Columbia Threadneedle	0	0	132,700	Withhold
FRANKLIN STRATEGIC SERIES	119,862	0	0	For
Global X	25,987	0	78,333	Mixed
First Trust	0	0	96,906	Withhold

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

3. 2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 14 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%

FOR: 43,215,571AGAINST: 2,904,714

Details: description as filed, official tally, votes by 254 asset managers

Description as filed by funds: To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."

TWIST BIOSCIENCE CORP.’s own tally for this item (“2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")”): 43,215,571 for, 2,904,714 against — passed, per its Form 8-K filed February 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") The Company's stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company's NEOs by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 73 asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Against	Abstain	Vote
ARK ETF Trust	6,775,445	0	0	For
Vanguard	5,376,144	0	0	For
Artisan	4,556,371	0	0	For
State Street	1,994,734	0	0	For
BlackRock	1,223,059	0	0	For
Invesco	930,956	0	0	For
BNY Mellon	0	882,394	0	Against
Dimensional	859,476	0	0	For
JPMorgan	782,827	0	0	For
WILLIAM BLAIR FUNDS	756,519	0	0	For
Charles Schwab	448,232	0	0	For
AIG/SunAmerica	261,088	0	0	For
Bridge Builder Trust	256,401	0	0	For
Fidelity	244,341	0	0	For
Direxion Shares ETF Trust	229,799	0	0	For
OLD WESTBURY FUNDS INC	216,180	0	0	For
Brighthouse	191,846	0	7,164	For
Equitable	171,913	0	0	For
TIAA	168,671	0	0	For
Jackson National	154,145	0	0	For
AMERICAN BEACON FUNDS	138,146	0	0	For
Columbia Threadneedle	132,700	0	0	For
FRANKLIN STRATEGIC SERIES	119,862	0	0	For
Global X	104,320	0	0	For
First Trust	96,906	0	0	For

Fund voting reports, all 73 managers: 27,147,917 for, 882,394 against, 7,164 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 201 asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Against	Vote
Nikko Asset Management Americas, Inc.	3,236,355	0	For
State Street	3,068,801	0	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	2,827,175	0	For
Maryland State Retirement & Pension System	2,000,000	0	For
BlackRock	1,864,641	0	For
JPMorgan	1,769,684	0	For
Man Group plc	1,637,740	0	For
UBS	0	1,165,195	Against
Invesco	1,116,461	0	For
Newton Investment Management North America, LLC	0	979,393	Against
Citadel	571,412	0	For
BAILLIE GIFFORD & CO LTD	565,900	0	For
Charles Schwab	448,232	0	For
NORDEA INVESTMENT MANAGEMENT AB	0	377,148	Against
NEW YORK STATE COMMON RETIREMENT FUND	370,849	0	For
Nikko Asset Management Co., Ltd.	347,088	0	For
Ensign Peak Advisors, Inc	262,943	0	For
Rafferty Asset Management, LLC	229,799	0	For
GEODE CAPITAL MANAGEMENT, LLC	184,418	0	For
Nuveen	178,004	0	For
Goldman Sachs	172,263	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	165,812	0	For
FRANKLIN ADVISERS INC	154,666	0	For
LORD, ABBETT & CO. LLC	151,615	0	For
Dimensional	149,137	0	For

Institutional-manager reports, all 201 managers: 23,452,443 for, 2,757,324 against, 2,902 abstained, 1,264 not voted, 45 unknown. Showing the 25 largest; see all in the interactive database.

4. 3. Ratification of Appointment of Independent Registered Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%

FOR: 52,195,318AGAINST: 61,548

Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2024.

TWIST BIOSCIENCE CORP.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Accounting Firm”): 52,195,318 for, 61,548 against — passed, per its Form 8-K filed February 7, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for the fiscal year ending September 30, 2024 by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 25,085,279 for, 7,164 abstained.

FOR

FOR: 25,085,279ABSTAIN: 7,164

Largest asset managers voting on “RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Abstain	Vote
ARK ETF Trust	6,775,445	0	For
Vanguard	5,376,144	0	For
State Street	1,994,734	0	For
Artisan	1,611,932	0	For
BlackRock	1,223,059	0	For
Invesco	930,956	0	For
BNY Mellon	882,394	0	For
Dimensional	859,476	0	For
JPMorgan	782,827	0	For
WILLIAM BLAIR FUNDS	756,519	0	For
Charles Schwab	448,232	0	For
AIG/SunAmerica	261,088	0	For
Bridge Builder Trust	256,401	0	For
Fidelity	244,341	0	For
Direxion Shares ETF Trust	229,799	0	For
OLD WESTBURY FUNDS INC	216,180	0	For
Brighthouse	191,846	7,164	For
Equitable	171,913	0	For
TIAA	168,671	0	For
Jackson National	154,145	0	For
AMERICAN BEACON FUNDS	138,146	0	For
Columbia Threadneedle	132,700	0	For
FRANKLIN STRATEGIC SERIES	119,862	0	For
Global X	104,320	0	For
First Trust	96,906	0	For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

Largest TWIST BIOSCIENCE CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,779,000 shares outstanding at the time of that meeting.

Fund voting reports: top TWIST BIOSCIENCE CORP. shareholders by shares voted on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named…”, 2023-2024
#	Asset manager	% of shares outstanding
1	ARK ETF Trust	11.73%
2	Vanguard	9.30%
3	Artisan	7.89%
4	State Street	3.45%
5	BlackRock	2.12%
6	Invesco	1.61%
7	BNY Mellon	1.53%
8	Dimensional	1.49%
9	JPMorgan	1.35%
10	WILLIAM BLAIR FUNDS	1.31%

Institutional-manager reports: top TWIST BIOSCIENCE CORP. shareholders by shares voted on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Nikko Asset Management Americas, Inc.	5.60%
2	State Street	5.31%
3	WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	4.89%
4	Maryland State Retirement & Pension System	3.46%
5	BlackRock	3.23%
6	JPMorgan	3.06%
7	Man Group plc	2.83%
8	UBS	2.02%
9	Invesco	1.93%
10	Newton Investment Management North America, LLC	1.70%

Reported TWIST BIOSCIENCE CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

TWIST BIOSCIENCE CORP. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
ARK Investment Management LLC	12.48%	13G
BlackRock	10.69%	13F
Vanguard Group	9.98%	13F
State Street Corporation	7.66%	DEF14A
JPMorgan Chase & Co.	6.63%	DEF14A
William Blair Investment Management, LLC	6.14%	13G
FMR LLC	5.34%	DEF14A
Nikko Asset Management Americas, Inc.	5.08%	DEF14A
Invesco	4.25%	13F
Millennium Management	3.85%	13F

Percentages above are of 57,779,000 shares outstanding, as reported by TWIST BIOSCIENCE CORP. on its Form 10-Q dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TWIST BIOSCIENCE CORP.’s 10-Q dated December 31, 2023. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At TWIST BIOSCIENCE CORP.'s shareholder meeting held February 6, 2024, in the 2023-2024 proxy season, 257 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,263 separate fund positions. On the most widely held item on that ballot — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — TWIST BIOSCIENCE CORP.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: TWIST BIOSCIENCE CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on February 7, 2024.

TWIST BIOSCIENCE CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.